Dividends4Life submits:
The markets have seen some significant gains since their March lows. Each time this occurs there is a new round of experts calling the bottom. Time and time again the market throws them a cruel twist and heads lower. Will this time be different?

Complete Story »
Go to Source

• 0 Comments

Brendan Wagner submits:
While it’s also a fantastic ditty by Def Leppard, Rock of Ages (ROAC) is a very old company specializing in "memorial" products - think headstones, mausoleum products, etc.
Rock of Ages reported a dramatic increase in earnings this morning, with earnings per share of 19 cents versus 10 cents a year ago. Shares are [...]

• 0 Comments

,a href=’http://www.dominoanalytics.com/’>Brian Coleman submits:
China Medicine (CHME) is scheduled to report 2Q’09 earnings this Thursday morning, August 13. While there is no consensus estimates or management guidance for investors to base expectations on, we believe the company’s balance sheet offers some important clues as it pertains to ball-parking China Medicine’s results. And these clues lead us [...]

• 0 Comments

Recently, Genzyme (GENZ) has been in the news more than Lindsay Lohan because of the viral contamination problems at its Boston suburb facility. The analysts covering Genzyme have been mixed about its prospects - UBS and Goldman both downgraded Genzyme citing the manufacturing issues and a competing drug being developed by Shire plc (SHPGY). On [...]

• 0 Comments

Jeffrey Dean Brown submits:
I always try to remain objective about the stocks that I write about and invest in. I have experienced the pain of falling in love with a stock that blinds me to its warts and blemishes. I must admit that I am very attracted to the stock that is the [...]

• 0 Comments